Mark Thomson is a biotechnology commercial leader with extensive experience in marketing and product management. They served as Vice President of Marketing at Epizyme from 2020 to 2022 and previously held various roles at Johnson & Johnson, including Regional Business Director for Gastroenterology. Mark has been with Sanofi since 2023, currently as VP, Global Commercial Lead for IBD & TL1a, following their role as Global Lead for New Product Planning. Mark earned an MBA in Marketing from UNC Kenan-Flagler Business School and a B.S. in Biology and Economics from Bates College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices